Sanofi fronts €300M to partner up with Innovent on China market, eyeing quick pivot to commercialization – Endpoints News

A federal appeals court on Tuesday denied prosecutors’ attempt to lengthen the sentences of two former GSK scientists who pleaded guilty to stealing trade secrets.

Yu Xue and Tao Li pleaded guilty back in 2018 to conspiracy to steal trade secrets, after they, along with others, formed a pharmaceutical company in China called Renopharma using hundreds of stolen documents from GSK, according to court documents. Xue, a former top chemist at GSK’s Upper Merion, PA, facility, was accused of stealing more than 200 documents, some of which contained trade secrets about pharmaceutical products under development, research data, and development and manufacturing processes.

Keep reading Endpoints with a free subscription

Unlock this story instantly and join 147,100+ biopharma pros reading Endpoints daily — and it’s free.


Leave a Comment

Your email address will not be published.